A Test of Neural Inertia in Humans With Xenon

Completed · Phase 2

Conditions studied: Neurocognitive Dysfunction

In brief

The dual objectives of this study are to determine if the phenomenon of neural inertia is present in humans and to determine whether the order of neurocognitive function is invariant among anesthetic agents. This study will enroll 24 healthy volunteers, ages 20-40 years, who will receive xenon gas (concentrations ranging from 0% to 60%) delivered via inhaled route through the ENHANCER 3000.

Key facts

Study ID
NCT02768727
Run by
University of Pennsylvania
People needed
21
Starts
2016-04-01
Expected to finish
2021-12-01
Last updated by the study team
2022-07-08

Who can join

Age: 20 and older, up to 40. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.